These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23826700)

  • 1. The long and winding road that leads to a cure for epidermolysis bullosa.
    Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
    Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls.
    Tolar J; Wagner JE
    Exp Dermatol; 2012 Dec; 21(12):896-900. PubMed ID: 23016552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular therapies for epidermolysis bullosa.
    Has C; Kiritsi D
    G Ital Dermatol Venereol; 2013 Feb; 148(1):65-72. PubMed ID: 23407078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa: prospects for cell-based therapies.
    Uitto J
    J Invest Dermatol; 2008 Sep; 128(9):2140-2. PubMed ID: 18695685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders.
    Hünefeld C; Mezger M; Kern JS; Nyström A; Bruckner-Tuderman L; Müller I; Handgretinger R; Röcken M
    Exp Dermatol; 2013 Mar; 22(3):162-7. PubMed ID: 23489418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
    Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
    Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy.
    Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E
    Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa].
    Laimer M; Lanschützer CM; Nischler E; Klausegger A; Diem A; Pohla-Gubo G; Bauer JW; Hintner H
    Hautarzt; 2009 May; 60(5):378-88. PubMed ID: 19430749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
    Intong LR; Murrell DF
    Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in epidermolysis bullosa.
    Abdul-Wahab A; Petrof G; McGrath JA
    Immunotherapy; 2012 Dec; 4(12):1859-67. PubMed ID: 23240753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa.
    Popenhagen MP; Genovese P; Blishen M; Rajapakse D; Diem A; King A; Chan J; Pellicer Arasa E; Baird S; Ferreira da Rocha AC; Stitt G; Badger K; Zmazek V; Ambreen F; Mackenzie C; Price H; Roberts T; Moore Z; Patton D; Murphy P; Mayre-Chilton K
    Orphanet J Rare Dis; 2023 Sep; 18(1):268. PubMed ID: 37667330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa.
    Bruckner-Tuderman L; Has C
    Matrix Biol; 2014 Jan; 33():29-34. PubMed ID: 23917088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic abnormalities and clinical classification of epidermolysis bullosa.
    Mitsuhashi Y; Hashimoto I
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S29-33. PubMed ID: 12677430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited epidermolysis bullosa.
    El Hachem M; Giancristoforo S; Diociaiuti A
    G Ital Dermatol Venereol; 2014 Dec; 149(6):651-62. PubMed ID: 25279494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary epidermolysis bullosa.
    Wright JT; Fine JD
    Semin Dermatol; 1994 Jun; 13(2):102-7. PubMed ID: 8060821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for inherited skin fragility disorders.
    Has C; Kiritsi D
    Exp Dermatol; 2015 May; 24(5):325-31. PubMed ID: 25916580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational Treatments for Epidermolysis Bullosa.
    Hou PC; Wang HT; Abhee S; Tu WT; McGrath JA; Hsu CK
    Am J Clin Dermatol; 2021 Nov; 22(6):801-817. PubMed ID: 34292508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
    Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
    J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.